Clinical Study

Fistuloclysis Improves Liver Function and Nutritional Status in Patients with High-Output Upper Enteric Fistula

Table 3

Laboratory and clinical variables before and after 28-day treatments in the two groups.

VariablesGroupsBaselineDay 14Day 28Delta Value

TB ( mol/L)Fistuloclysis <
Control
0.243
DB ( mol/L)Fistuloclysis <
Control
0.139
IB ( mol/L)Fistuloclysis
Control
0.1830.285
ALT (U/L)Fistuloclysis
Control 0.181
0.058
ALP (U/L)Fistuloclysis <
Control
0.182<
GGT (U/L)Fistuloclysis <
Control <
0.422
TP (g/L)Fistuloclysis <
Control
0.763<
Alb (g/L)Fistuloclysis <
Control 0.078
0.472<
WBC (109/L)Fistuloclysis 0.418
Control 0.068
0.3040.061
CRP (mg/L)Fistuloclysis 0.073
Control 0.081
Fistula output (mL/day)Fistuloclysis <
Control 0.052
0.152<

TB: total bilirubin; DB: direct bilirubin; IB: indirect bilirubin; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: -glutamyltransferase; TP: total protein; Alb: albumin; WBC: white blood cells; CRP: C-reactive protein. Delta value was defined as the changes from baseline to day 28 for each variable. indicated the time-dependent changes of variables within groups. indicated comparisons between the fistuloclysis group and the control group (for the baseline value and the delta values, resp.). Data were presented as mean ± SD. value < 0.05 was deemed significant.